Prognostic value of monolayer culture patterning in primary cell culture of oesophageal cancer. 1996

Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
First Department of Surgery, Kyoto University, Japan.

The growth of primary cell cultures of oesophageal cancer was compared with the clinical outcome of patients from whom the cancers were taken. Ninety-three patients underwent curative resection, with no operative deaths, and were divided into three groups according to the monolayer culture pattern of the primary cell culture: culture from 43 patients (46 per cent) grew no malignant cells (group 1), 21 (23 per cent) produced monolayer epithelial growth (group 2) and the rest (from 29 patients) established cell lines (group 3). The 5-year survival rate of patients in group 2 (29 per cent) and group 3 (23 per cent) was significantly lower (P < 0.005) than that of those in group 1 (51 per cent). Monolayer epithelial growth potential is a significant prognostic factor in patients with oesophageal cancer.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
June 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
August 2000, The European journal of surgery = Acta chirurgica,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
November 2009, Langmuir : the ACS journal of surfaces and colloids,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
January 2003, British journal of cancer,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
January 2016, Histopathology,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
September 2011, British journal of cancer,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
August 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
March 2018, Interactive cardiovascular and thoracic surgery,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
March 2000, The British journal of surgery,
Y Shimada, and Y Kanda, and I Shibagaki, and M Kato, and G Watanabe, and H Tanaka, and M Kano, and M Imamura
April 2005, Journal of clinical pathology,
Copied contents to your clipboard!